Discussion of targeting proteins in vivo: in vitro guidelines
- 31 May 2006
- journal article
- editorial
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 33 (4), 449-451
- https://doi.org/10.1016/j.nucmedbio.2006.03.008
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Binding of the Positron Emission Tomography Tracer Pittsburgh Compound-B Reflects the Amount of Amyloid-β in Alzheimer's Disease Brain But Not in Transgenic Mouse BrainJournal of Neuroscience, 2005
- Mass effect of injected dose in small rodent imaging by SPECT and PETNuclear Medicine and Biology, 2005
- Selective binding of 2-[125I]iodo-nisoxetine to norepinephrine transporters in the brainNuclear Medicine and Biology, 2004
- Measuring the in Vivo Binding Parameters of [18F]-Fallypride in Monkeys Using a PET Multiple-Injection ProtocolJournal of Cerebral Blood Flow & Metabolism, 2004
- Synthesis of a [2-Pyridinyl-18F]-labelled fluoro derivative of (−)-Cytisine as a candidate radioligand for brain nicotinic α4β2 receptor imaging with PETBioorganic & Medicinal Chemistry, 2003
- Development of ligands for in vivo imaging of cerebral nicotinic receptorsBehavioural Brain Research, 2000
- Synthesis and in vivo evaluation of (E)-N-[(11)C]Methyl-4- (3-pyridinyl)-3-butene-1-amine ([(11)C]metanicotine) as a nicotinic receptor radioligand.Nuclear Medicine and Biology, 2000
- Human neuronal nicotinic receptorsProgress in Neurobiology, 1997
- Multiple binding sites for nicotine receptor antagonists in inhibiting [3H](−)-nicotine binding in rat cortexNeuropharmacology, 1993
- [3H]mecamylamine binding to rat brain membranesBiochemical Pharmacology, 1990